5 completed, 1 enrolling by invitation, 1 withdrawn. 4 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Enrolling by invitation 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Roche Global Development: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer PIVKA-II and GAAD score calculation - Liver Cirrhosis, Hepatitis B, Chronic | Not applicable | Enrolling by invitation | Siriraj Hospital | 2100 | 2026-02-02 | 2026-04-24 |
| Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures Atezolizumab 1200 mg IV, Tiragolumab 600 mg IV - Metastatic Cancer Lung, Advanced Lung Cancer | Phase 2 | Withdrawn | Gustave Roussy, Cancer Campus, Grand Paris | 2025-01-30 | 2026-03-23 | |
| Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer oxaliplatin, capecitabine - Gastric Cancer, Esophageal Cancer | Phase 2 | Completed | University of Southern California | 75 | 2004-12-28 | 2026-07-30 |
| Tarceva and Capecitabine for Pancreatic Cancer Capecitabine, OSI-774 - Pancreatic Cancer, Neoplasm Metastasis | Phase 2 | Completed | Dana-Farber Cancer Institute | 32 | 2003-10-01 | 2009-11-02 |
| A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Not applicable | Completed | Roche Global Development | 280 | 2005-06-24 | |
| A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Not applicable | Completed | Roche Global Development | 450 | 2005-06-24 | |
| An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Not applicable | Completed | Roche Global Development | 20 | 2005-06-24 |
Acquired Immunodeficiency Syndrome (3) · Cytomegalovirus Retinitis (3) · HIV Infections (3) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (3) · Retinitis (3) · Cytomegalovirus Infections (2) · Carcinoma, Hepatocellular (1) · Esophageal Neoplasms (1) · Hepatitis B, Chronic (1) · Hepatitis C, Chronic (1) · Liver Cirrhosis (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Ganciclovir (3) · Capecitabine (2) · Erlotinib Hydrochloride (1) · Oxaliplatin (1) · Tiragolumab (1) · atezolizumab (1)
United States (5) · Canada (1) · Thailand (1)
Matthew Kulke, MD (1) · Syma Iqbal, M.D. (1)
2023 (1)